The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of OxyContin.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

The new settlement deal could net Pennsylvania and Delaware as much as $212 million and $27 million, respectively, in payouts.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.

Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...